Zhuldyz Akisheva, UNODC Regional Office South Africa: Welcome. Ms. Molekane, South Africa: We have a regulatory and institutional responsibility to respond to the needs of women, drug users and other stakeholders. The main issue is NPS that hampers our treatment and recovery responses due to its constantly changing nature. WDR continues to pose serious threats. …
Side Events
Side event: Myanmar drug policy reform and civil society perspective
Organized by the Government of Myanmar and the Transnational Institute Ernestien Jensema, Transnational Institute (Chair): Welcome. Pol. Brig. Gen Win Naing, CCDAC “Strategic priorities of the National Drug Control Policy”: I will talk about the national drug control strategy and the policy of Myanmar. With reference to the UNGASS 2016 outcome document, we developed the national …
Side Event: Youth Participation in Drug Use Prevention: A Way to Build Healthy, and Prosperous Communities and Societies
Organized by Kyrgyzstan and the Russian Federation, and Turkish Green Crescent Society and UNODC Drug Prevention and Health Branch. Elizabeth Mattfeld, Prevention, Treatment and Rehabilitation Section, Drug Prevention and Health Branch, UNODC: UNODC Handbook on Youth Participation in Drug Prevention Work. We have meaningful engagement of youth. Youth driving creation of this document. Defines youth …
Side Event: Bridging the Gaps between Crime and Development Perspectives in Drug Policy: The Drugs & Development Hub
[…] UNODC AD (stand-in): WDP and Sustainable Development: a complex relationship – responses impact each other. We cannot look at these areas out of context. Drug use undermines goal 5 (gender equality) – women take more pharmaceutical medications and men are more into drugs like cocaine and heroin. Clear lack of services for women. Women …
Side event: Drug crypto markets beyond 2020: Policy, enforcement, harm, and resilience
Organized by the Government of the Netherlands, Asociación Bienestar y Desarollo (Energy Control), the Global Drug Policy Observatory and the International Drug Policy Consortium Anke ter Hoeve, Netherlands: The Netherlands is a staunch supporter of evidence based drug policymaking. We had a side event on the matter and submitted a resolution which commanded great support. …
Side Event: Drug Crypto Markets Beyond 2020: Policy, Enforcement, Harm, and Resilience
Organized by the Netherlands, and Asociacion Bienestar y Desarollo (Energy Control), Global Drug Policy Observatory and International Drug Policy Consortium. Surprisingly little research on drug crypto markets. Crypto markets continue to function despite high profile law enforcement actions. Data suggests that production of drugs on crypto markets remain robust and in some contexts are increasing. …